​

Funding Round

Post-IPO Equity - Ginkgo Bioworks

Post-IPO Equity - Ginkgo Bioworks

Investment Firm

Overview

Ginkgo Bioworks is a developer of biological engineering products and custom microbes across multiple markets.

Announced Date

Sep 17, 2021

Funding Type

Post Ipo Equity

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

10

Investor Name
Participant InvestorArrowMark Partners
Participant InvestorT. Rowe Price
Participant InvestorBaillie Gifford
Participant InvestorCascade Investment
Participant InvestorPutnam Investments

Round Details and Background

Ginkgo Bioworks raised $775000000 on 2021-09-17 in Post-IPO Equity

Ginkgo Bioworks is a developer of biological engineering products and custom microbes across multiple markets.

Company Funding History

18

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 10, 2024
Grant - Ginkgo Bioworks
1-undefined
Jun 08, 2016
Series C - Ginkgo Bioworks
6-100.0M
Jul 23, 2015
Series B - Ginkgo Bioworks
11-53.3M
Jul 16, 2014
Seed Round - Ginkgo Bioworks
14-1.0M

Recent Activity

There is no recent news or activity for this profile.